Novel GLP-1 Cut Heavy Drinking Days in Alcohol Use Disorder

Coverage, in order

1. 1d ago
   first Baylor College of Medicine Blogs indie study

   VA trial to study effects of GLP-1s for alcohol use disorder among veterans

   Dr. Chris Verrico discusses how GLP-1s show promise to treat alcohol use disorder among veterans and hopeful outcomes for the study.

2. 11h ago
   
   MedPage Today indie randomized trial

   Novel GLP-1 Cut Heavy Drinking Days in Alcohol Use Disorder

   (MedPage Today) -- The investigational glucagon/GLP-1 dual receptor agonist pemvidutide significantly reduced the number of heavy drinking days (HDDs) per week in patients with moderate-to-severe alcohol use disorder (AUD), the phase II RECLAIM...

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.